Navigation Links
Health Department Announces First Doses of H1N1 Vaccine Arrive in Pennsylvania

HARRISBURG, Pa., Oct. 6 /PRNewswire-USNewswire/ -- Pre-registered and certified providers in the southwest, southeast, and north-central regions of the state have begun to receive the first doses of the live attenuated pandemic H1N1 influenza vaccine, also known by the brand name FluMist, the Pennsylvania Department of Health said today.

This vaccine, which comes as a nasal spray, is recommended primarily for healthy persons between the ages of 2-49 years of age. It is not indicated for several of the groups at highest priority for vaccination, including pregnant women, children under two years of age, those with certain underlying health conditions, and healthcare providers who care for persons with significant impairments in their immune system. Live virus vaccines like LAIV are generally not given to these groups of people.

The department recommended this limited number of doses be used primarily in healthy children ages 5-9 years. This recommendation was made based on three factors: the type of vaccine available, the Advisory Council on Immunization Practice recommendations for priority use of the vaccine, and the patterns of disease currently being seen in Pennsylvania. In addition, children under age 10 require two doses of vaccine at least three weeks apart in order for adequate levels of protection to develop. Using available vaccine in the 5-9 year age group will allow immunity to build in children experiencing significant levels of disease as quickly as possible.

Department officials will work with registered providers to assure vaccine reaches individuals in the prioritized groups. The department expects to have at least 2.5 million doses available by the end of October for distribution to all parts of the state. Eventually, vaccine will be available to anyone who wishes to receive it and reduce the likelihood that they will develop pandemic A/H1N1 influenza and its related complications.

To find an H1N1 vaccination site, those in the recommended groups should contact their healthcare provider or their child's school. If they will not be providing the vaccine, please call 1-877-PA-Health for more information about how to receive the vaccine.

Additional vaccine is expected to be available for those not in the recommended groups by early November.

For more information on vaccination sites for the general public, visit

Media contact: Stacy Kriedeman, 717-576-3077

SOURCE Pennsylvania Department of Health

SOURCE Pennsylvania Department of Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Formatta Presents Forms-Driven Business Process Optimization Webinar for Healthcare on Wednesday, October 14 at 1 p.m. Eastern
2. Tailoring Breast Cancer Treatment, from Harvard Women's Health Watch
3. Valensa to Market Neptune Krill Oil NKO(R) Formulations for Joint Health and Eye Health Dietary Supplements
4. Michigan Society for Healthcare Planning and Marketing to Hold Fall Conference
5. Sleep HealthCenters Now Accepting Students for A-STEP Sleep Technologist Program
6. HealthCentrals Grows to More Than 3,000 Health and Wellness Bloggers
7. Arcadian Health Plans Expand Their Medicare Health Plan Offerings and Enter Four New States
8. QHR Ranked 7th Largest Healthcare Management Consulting Firm in United States
9. Social Support: Impact on Health and the Bottom Line
10. Blue Cross and Blue Shield Companies Honored for Innovative Programs That Help Consumers Live Healthier Lives
11. Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: